Brief: Check-Cap Receives FDA IDE Approval For Pivotal Study Of C-Scan
March 15 (Reuters) - Check Cap Ltd CHEK.O :
* CHECK-CAP RECEIVES FDA IDE APPROVAL FOR PIVOTAL STUDY OF
C-SCAN®
* CHECK CAP LTD - EXPECTS TO COMMENCE U.S. PIVOTAL TRIAL IN
LATE
2021
Source text for Eikon: ID:nPnbX00g6a
Further company coverage: CHEK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mbody Ai
See all newsBrief: Check-Cap Ltd. Announces Pricing Of $10 Million Public Offering Of Ordinary Shares
Brief: Check-Cap Announces $12.50 Mln Firm Commitment Public Offering Of Ordinary Shares
Brief: Check-Cap (Mbai) Advances Merger With Mbody Ai Reverse Share Split Effective
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM